Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H24N4O |
| Molecular Weight | 372.4629 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C(CN1C=C(C2=NC(CC3=CC=CC=C3)=NO2)C4=C1C=CC=C4)N5CCCC5
InChI
InChIKey=RUVOQWMACBDQDK-UHFFFAOYSA-N
InChI=1S/C23H24N4O/c1-2-8-18(9-3-1)16-22-24-23(28-25-22)20-17-27(15-14-26-12-6-7-13-26)21-11-5-4-10-19(20)21/h1-5,8-11,17H,6-7,12-16H2
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-BzODZ-EPyr
Created by
admin on Sat Dec 16 19:06:47 GMT 2023 , Edited by admin on Sat Dec 16 19:06:47 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BZODZ-EPYR
Created by
admin on Sat Dec 16 19:06:47 GMT 2023 , Edited by admin on Sat Dec 16 19:06:47 GMT 2023
|
PRIMARY | BzODZ-EPyr is an indole based synthetic cannabinoid that has been sold as a designer drug in Russia. It acts as a CB1 receptor agonist with a pKB value of 7.2 and demonstrates that replacing the ketone in 3-carbonylindoles with an oxadiazole spacer does generally not lead to activity loss. | ||
|
9842447
Created by
admin on Sat Dec 16 19:06:47 GMT 2023 , Edited by admin on Sat Dec 16 19:06:47 GMT 2023
|
PRIMARY | |||
|
422564-85-0
Created by
admin on Sat Dec 16 19:06:47 GMT 2023 , Edited by admin on Sat Dec 16 19:06:47 GMT 2023
|
PRIMARY | |||
|
WSQ49D7D2Q
Created by
admin on Sat Dec 16 19:06:47 GMT 2023 , Edited by admin on Sat Dec 16 19:06:47 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
